EMP3 and central nervous system cancer: In particular, EMP3 has been found to upregulate the surface expression of αvβ3 integrin, activate focal adhesion kinase and Src kinase, promote cell migration and invasion, promote tumor growth in vivo, and serve as a prognostic evaluation factor for glioma [38, 39].